ACCELERATE DIAGNOSTICS INC's ticker is and the CUSIP is 00430HAB8. A total of 15 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,606,000 | -39.5% | 5,500,000 | -31.2% | 0.05% | -47.7% |
| Q4 2021 | $5,959,000 | +5.9% | 8,000,000 | 0.0% | 0.09% | +10.0% |
| Q3 2021 | $5,625,000 | +8.9% | 8,000,000 | 0.0% | 0.08% | +100.0% |
| Q2 2021 | $5,165,000 | -1.5% | 8,000,000 | 0.0% | 0.04% | -23.1% |
| Q1 2021 | $5,245,000 | +15.8% | 8,000,000 | 0.0% | 0.05% | -1.9% |
| Q4 2020 | $4,529,000 | -10.3% | 8,000,000 | 0.0% | 0.05% | -26.4% |
| Q3 2020 | $5,050,000 | -11.0% | 8,000,000 | 0.0% | 0.07% | -47.4% |
| Q2 2020 | $5,672,000 | -12.8% | 8,000,000 | -33.3% | 0.14% | -21.3% |
| Q1 2020 | $6,505,000 | -47.2% | 12,000,000 | -25.0% | 0.17% | -37.4% |
| Q4 2019 | $12,331,000 | -3.6% | 16,000,000 | 0.0% | 0.28% | +10.8% |
| Q3 2019 | $12,794,000 | -4.4% | 16,000,000 | 0.0% | 0.25% | +73.1% |
| Q2 2019 | $13,382,000 | – | 16,000,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |